Biotech drugs used to treat rheumatoid arthritis may not increase the risk of cancer, as much as feared!

Reuters alert - Two biotech drugs used to treat rheumatoid arthritis-- Abbott Laboratories Inc.'s Humira and Johnson & Johnson's Remicade -- may raise the risk of cancer and infections but not as much as was feared, researchers said on Tuesday.

A series of letters published in the Journal of the American Medical Association show that several teams have taken a fresh look at the safety of the two drugs and find that they may double the risk of cancer and infections.

Most of the researchers, and the U.S. Food and Drug Administration, agree that patients need to know about the risks but say the benefits mean the drugs should stay on the market.

Read more...

Related News EU clears arthritis drug